Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03JRG
|
||||
| Former ID |
DIB018015
|
||||
| Drug Name |
VU0364739
|
||||
| Synonyms |
VU 0364739
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Coagulation [ICD10:I80-I82] | Clinical trial | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C26H27FN4O2
|
||||
| InChI |
InChI=1S/C26H27FN4O2/c27-22-6-3-7-23(17-22)31-18-29-25(33)26(31)10-13-30(14-11-26)15-12-28-24(32)21-9-8-19-4-1-2-5-20(19)16-21/h1-9,16-17H,10-15,18H2,(H,28,32)(H,29,33)
|
||||
| InChIKey |
MSTXJJGAXXJCBY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | PLD2 | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5287). | ||||
| REF 2 | Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor. J Med Chem. 2010 Sep 23;53(18):6706-19. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.